Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.
The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback